Inhibiting the Inhibitor in Synovial Macrophages and Cancer Immunotherapy-Associated Inflammatory Arthritis

被引:0
|
作者
Shah, Nisarg J. [1 ]
Bottini, Nunzio [2 ]
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1002/art.42743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:505 / 506
页数:2
相关论文
共 50 条
  • [31] Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects
    Cortellino, S.
    Quagliariello, V.
    Delfanti, G.
    Blazevits, O.
    Chiodoni, C.
    Maurea, N.
    Di Mauro, A.
    Tatangelo, F.
    Pisati, F.
    Shmahala, A.
    Lazzeri, S.
    Spagnolo, V.
    Visco, E.
    Tripodo, C.
    Casorati, G.
    Dellabona, P.
    Longo, V. D.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Outcomes and Adverse Events in Patients with Cancer after Diagnosis of Immunotherapy-Associated Diabetes Mellitus: A Retrospective Cohort Study
    Duvalyan, Eva
    Brondfield, Sam
    Rushakoff, Robert J.
    Anderson, Mark S.
    Quandt, Zoe
    CANCERS, 2024, 16 (09)
  • [33] Checkpoint Inhibitor Immunotherapy Induced Inflammatory Arthritis Secondary to Nivolumab and Ipilumab: A Pediatric First
    Storwick, John
    Tam, Herman
    Houghton, Kristin
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 76 - 77
  • [34] Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation
    Braaten, Tawnie
    Brahmer, Julie
    Forde, Patrick
    Le, Dung
    Lipson, Evan
    Naidoo, Jarushka
    Schollenberger, Megan
    Zheng, Lei
    Jones, Michelle
    Shah, Ami
    Bingham, Clifton
    Cappelli, Laura
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
    Braaten, Tawnie J.
    Brahmer, Julie R.
    Forde, Patrick M.
    Le, Dung
    Lipson, Evan J.
    Naidoo, Jarushka
    Schollenberger, Megan
    Zheng, Lei
    Bingham, Clifton O., III
    Shah, Ami A.
    Cappelli, Laura C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (03) : 332 - 338
  • [36] Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first
    Storwick, John A.
    Tam, Herman
    Rosenbaum, Daniel G.
    Houghton, Kristin
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [37] Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis, by an Fcγ receptor I-directed immunotoxin
    van Roon, JAG
    van Vuuren, AJ
    Wijngaarden, S
    Jacobs, KMG
    Bijlsma, JWJ
    Lafeber, FPJG
    Thepen, T
    van de Winkel, JGJ
    ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1229 - 1238
  • [38] Influence of anti-inflammatory Therapies on the Interaction between synovial Fibroblasts and Macrophages in Patients with rheumatoid Arthritis
    Schmeller, Maike
    Diller, Magnus
    Hasseli, Rebecca
    Knothe, Anna
    Rehart, Stefan
    Tarner, Ingo
    Hermann, Walter
    Lange, Uwe
    Mueller-Ladner, Ulf
    Neumann, Elena
    INTERNIST, 2021, 62 (SUPPL 2): : 183 - 183
  • [39] Pro-inflammatory interleukins in the synovial fluid of rheumatoid arthritis associated with joint hypermobility
    Punzi, L
    Pozzuoli, A
    Pianon, M
    Bertazzolo, N
    Oliviero, F
    Scapinelli, R
    RHEUMATOLOGY, 2001, 40 (02) : 202 - 204
  • [40] In situ reprogramming of tumor-associated macrophages enhances cancer immunotherapy
    Han, Yanjie
    Lu, Haifeng
    Gu, Zikuan
    Guan, Peixin
    Liu, Zhen
    NANO TODAY, 2024, 58